Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c5a5dc7c11cf171ceb132cb13a4045fe |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D515-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D498-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D498-16 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D498-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-505 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D495-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D498-02 |
filingDate |
2006-11-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2010-05-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_602373505707a535283eee412552eb39 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b6dbf844b4c9680339da6f0f54addc0e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f351984de3591dd117835c6268b490c5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4f5a08f14cabeaef40b22248fe370f58 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_368f8063b2671a0f0a3addaa60e2c789 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_35d6a4402c57fed1f913c12982fe7084 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3ce9934ba3c2622fc25fea1b3cad57c3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9504d81e853ec3348ff50d064806d0d4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c0c7dcf770ca2df13e382694722aacea |
publicationDate |
2010-05-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
EP-1951730-B1 |
titleOfInvention |
Heteroalkyl linked pyrimidine derivatives |
abstract |
The present invention relates to pyrimidine compounds that are useful as anti-proliferative agents. More particularly, the present invention relates to heteroalkyl linked and substituted pyrimidine compounds, methods for their preparation, pharmaceutical compositions containing these compounds and uses of these compounds in the treatment of proliferative disorders. These compounds may be useful as medicaments for the treatment of a number of proliferative disorders including tumours and cancers as well as other conditions or disorders associated with kinases. |
priorityDate |
2005-11-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |